post-thrombotic syndrome, in which the clots in the leg never heal, sometimes leading to loss of function of the legs, Lookstein said.
"This can transform somebody who would otherwise be a working member of the community and turn them into somebody unable to work, somebody who is bedbound," he said.
The authors of the new study, from the Medical University of Graz in Austria, looked at 46 patients (32 women and 14 men) who came to the dermatology department with SVT.
One-quarter of the patients had DVT, usually without symptoms. Of these, three-quarters had DVT in the same leg as the superficial vein thrombosis, 9 percent had DVT in the other leg and 18 percent had it in both legs, the researchers said.
Anybody with SVT should undergo routine screening with duplex ultrasound, which can be performed either in a doctor's office or by a vascular specialist, Lookstein said.
The findings were published in the July issue of the Archives of Dermatology.
More information
The U.S. National Heart, Lung, and Blood Institute has more on deep vein thrombosis.
SOURCES: Robert Rosen, M.D., director, vascular intervention, Lenox Hill Hospital, New York City; Robert Lookstein, M.D., associate professor, radiology and surgery, Mount Sinai School of Medicine, New York City; July 2009 Archives of Dermatology
'/>"/>Copyright©2009 ScoutNews,LLC. All rights reserved | |
Page: 1 2 Related medicine news :1.
Worlds First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe2.
Health clinic conditions may be to blame for decrease in primary care physicians3.
Aging Institute May Die Before its Time, Due To Economic Conditions Yet Washington Based Non-Profit Organization Forges Ahead with Scheduled Landmark Conference4.
Helen Sher Launches Her Rosacea Awareness Campaign 2009 to Help Sufferers of this Distressing Condition5.
Kids With Eye Condition at Risk for Poor Mental Health 6.
63 percent of RA patients suffer psychiatric disorders, with depressive spectrum conditions most likely7.
Omega-3 EPA: Treatment for a Heart Condition8.
XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration9.
Obesity and diabetes double risk of HF -- patients with both conditions very difficult to treat10.
Common migraine pain condition also prevalent in cluster headache11.
Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions